Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia

Blood Cancer Journal

Volumn 4, Issue 7, 2014, Pages

  Efanov, A ^a   Zanesi, N ^a   Coppola, V ^a   Nuovo, G ^a,b   Bolon, B ^c   Wernicle Jameson, D ^a   Lagana, A ^a   Hansjuerg, A ^a   Pichiorri, F ^a   Croce, C M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Phylogeny Inc   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HIGH MOBILITY GROUP A2 PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALOPECIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ENHANCER REGION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HMGA2 GENE; IMMUNE RESPONSE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; LYMPHADENOPATHY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PROMOTER REGION; PROTEIN EXPRESSION; SPLENOMEGALY; THYMOCYTE; TRANSGENIC MOUSE; YOUNG ADULT; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY;

ANIMALS; CELL PROLIFERATION; FEMALE; HMGA2 PROTEIN; HUMANS; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84905375534     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2014.46     Document Type: Article

References (21)

1. Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398-3406.
2. Horacek JM, Kupsa T, Vasatova M, Jebavy L, Zak P. Evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute lymphoblastic leukemia using biochip array technology. Exp Oncol 2013; 35: 229-230.
3. Chandra RK. Serum immunoglobulin levels in children with acute lymphoblastic leukaemia and their mothers and sibs. Arch Dis Child 1972; 47: 618-620.
4. Lin YW, Nichols RA, Letterio JJ, Aplan PD. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 2006; 107: 2540-2543.
5. Patel JL, Smith LM, Anderson J, Abromowitch M, Campana D, Jacobsen J et al. The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report. Br J Haematol 2012; 159: 454-461.
6. Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 2011; 19: 484-497.
7. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
8. Zhou X, Chada K. HMGI family proteins: architectural transcription factors in mammalian development and cancer. Keio J Med 1998; 47: 73-77.
9. Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M et al. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci USA 2001; 98: 7970-7975.
10. Odero MD, Grand FH, Iqbal S, Ross F, Roman JP, Vizmanos JL et al. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 2005; 19: 245-252.
11. Pierantoni GM, Santulli B, Caliendo I, Pentimalli F, Chiappetta G, Zanesi N et al. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 2003; 23: 363-367.
12. Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006; 9: 459-471.
13. Raeber AJ, Sailer A, Hegyi I, Klein MA, Rülicke T, Fischer M et al. Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci USA 1999; 96: 3987-3992.
14. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002; 99: 6955-6960.
15. Palamarchuk A, Zanesi N, Aqeilan RI, Efanov A, Maximov V, Santanam U et al. Tal1 transgenic expression reveals absence of B lymphocytes. Cancer Res 2006; 66: 6014-6017.
16. Morse 3rd HC, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002; 100: 246-258.
17. Kondo A, Imada K, Hattori T, Yamabe H, Tanaka T, Miyasaka M et al. A model of in vivo cell proliferation of adult T-cell leukemia. Blood 1993; 82: 2501-2509.
18. Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto AJ et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002; 21: 3190-3198.
19. Battista S, Fidanza V, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999; 59: 4793-4797.
20. Parolini M, Mecucci C, Matteucci C, Giussani U, Intermesoli T, Tosi M et al. Highly aggressive T-cell acute lymphoblastic leukemia with t(8;14)(q24;q11): extensive genetic characterization and achievement of early molecular remission and longterm survival in an adult patient. Blood Cancer J 2014; 4: e176.
21. Thoene S, Rawat VPS, Heilmeier B, Hoster E, Metzeler KH, Herold T. The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia. Leukemia 2009; 23: 649-655.